BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 5392781)

  • 21. Immunoglobulin levels and long-acting thyroid stimulator (LATS) in hyperthyroidism. A preliminary study.
    Yamakido M; Yokoyama M; Noguchi S
    Hawaii Med J; 1969; 29(2):118-9. PubMed ID: 5361480
    [No Abstract]   [Full Text] [Related]  

  • 22. [Serum thyrotropic hormone (T.S.H.) and the long acting stimulator substance (L.A.T.S.) in hyperthyroidism. Preliminary communication].
    Bonnyns M
    Rev Fr Etud Clin Biol; 1967 Jan; 12(1):77-9. PubMed ID: 6052803
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-acting thyroid stimulator (LATS) and immunofluorescent studies in patients with pretibial myxoedema.
    From E; Diederichsen H; Heydenreich G; Nielsen OS
    Dan Med Bull; 1973 Dec; 20(6):188-91. PubMed ID: 4591336
    [No Abstract]   [Full Text] [Related]  

  • 24. Thyroid suppression and the long-acting thyroid stimulator following radioactive iodine therapy for thyrotoxicosis.
    Alford FP; Larkins RG; Martin FI
    Aust N Z J Med; 1971 Nov; 1(4):339-45. PubMed ID: 5292990
    [No Abstract]   [Full Text] [Related]  

  • 25. [The etiopathogenic role of long-acting thyroid stimulator in thyrotoxicosis].
    Papazov G; Milanov S; Platonova E
    Vutr Boles; 1972; 11(2):59-62. PubMed ID: 4679953
    [No Abstract]   [Full Text] [Related]  

  • 26. Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease.
    McKenzie JM; McCullagh EP
    J Clin Endocrinol Metab; 1968 Aug; 28(8):1177-82. PubMed ID: 4175472
    [No Abstract]   [Full Text] [Related]  

  • 27. [The significance of the thyrotropic hormone (TSH), long-acting thyroid stimulator (LATS) and exophthalmos-producing factor (EPF) in various forms of thyroid hyperfunction].
    Horster FA; Schleusener H; Schimmelpfennig K
    Dtsch Med Wochenschr; 1967 Apr; 92(14):673-7. PubMed ID: 5337982
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical studies of long-acting thyroid stimulator].
    Eguchi Y
    Nihon Naibunpi Gakkai Zasshi; 1970 Nov; 46(8):939-52. PubMed ID: 4099204
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of iodine administration on the thyrotropic hormone and long-acting thyroid stimulator level in the plasma].
    Földes J; Krasznai I; Piroska E; Gesztesi E; Takács I
    Endokrinologie; 1967; 52(1):80-7. PubMed ID: 4171706
    [No Abstract]   [Full Text] [Related]  

  • 30. [Determination of thyrotropic hormone and long acting thyroid stimulator by the McKenzie technique. Critical study of the method].
    Bonnyns M
    Rev Fr Etud Clin Biol; 1968 Nov; 13(9):845-52. PubMed ID: 5709509
    [No Abstract]   [Full Text] [Related]  

  • 31. [The long-acting thyroid stimulator (LATS) in untreated and I-131 treated hyperthyreoses, following total thyroidectomy, as well as its relation to thyroid antibodies].
    Ziemke A; Weisbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W
    Klin Wochenschr; 1968 Oct; 46(19):1025-7. PubMed ID: 5727481
    [No Abstract]   [Full Text] [Related]  

  • 32. Pretibial myxedema and nonthyrotoxic thyroid disease.
    Lynch PJ; Maize JC; Sisson JC
    Arch Dermatol; 1973 Jan; 107(1):107-11. PubMed ID: 4118738
    [No Abstract]   [Full Text] [Related]  

  • 33. Mechanisms of Graves' disease and endocrine exophthalmos.
    Anderson DR
    Am J Ophthalmol; 1969 Jul; 68(1):46-57. PubMed ID: 4895778
    [No Abstract]   [Full Text] [Related]  

  • 34. [LATS and thyroid antibody level in the blood in Basedow's disease].
    Földes J; Takó J; Bános C; Gesztesi E; Varga I
    Orv Hetil; 1968 Aug; 109(33):1799-804. PubMed ID: 5714825
    [No Abstract]   [Full Text] [Related]  

  • 35. CLINICAL STUDIES ON THE LONG-ACTING THYROID STIMULATOR.
    NOGUCHI A; KURIHARA H; SATO S
    J Clin Endocrinol Metab; 1964 Feb; 24():160-5. PubMed ID: 14123839
    [No Abstract]   [Full Text] [Related]  

  • 36. Diagnosis of Graves' ophthalmopathy without hyperthyroidism: long-acting thyroid stimulator (LATS) determination as laboratory adjunct.
    Gharib H; Mayberry WE
    Mayo Clin Proc; 1970 Jun; 45(6):444-9. PubMed ID: 4193249
    [No Abstract]   [Full Text] [Related]  

  • 37. Thyroglobulin in serum after TSH stimulation in hyperthyroidism.
    Hjort T; Friis T; Lauridsen UB; Persson I
    Acta Endocrinol (Copenh); 1974 Apr; 75(4):699-706. PubMed ID: 4408388
    [No Abstract]   [Full Text] [Related]  

  • 38. Failure of long-acting thyroid stimulator globulin (LATS) and serum to stimulate thyroid function in the chick.
    Lepp A; Oliner L
    Endocrinology; 1967 Feb; 80(2):369-74. PubMed ID: 4163488
    [No Abstract]   [Full Text] [Related]  

  • 39. [Absent biological demonstration of "long-acting thyroid stimulator" (LATS) in endemic euthyroid iodine deficiency goiters].
    Stelzer M; Mertz DP
    Munch Med Wochenschr; 1969 Jun; 111(23):1306-9. PubMed ID: 5820134
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies of serum long-acting thyroid stimulator (LATS) in relation to exophthalmos after therapy for thyrotoxicosis.
    Hetzel BS; Mason EK; Wang HK
    Australas Ann Med; 1968 Nov; 17(4):307-11. PubMed ID: 4178378
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.